Serous Retinopathy Associated With Combination MEK and Fibroblast Growth Factor Receptor Inhibitor

Purpose: To present a case of a chemotherapy regimen combining a fibroblast growth factor receptor (FGFR) and mitogen-activated protein kinase kinase (MEK) inhibitor leading to serous retinopathy. Methods: A retrospective chart review of a single case was performed. Results: A 67-year-old man with p...

Descripción completa

Detalles Bibliográficos
Autores principales: Day, H. Russell, Finn, Avni P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621699/
https://www.ncbi.nlm.nih.gov/pubmed/37927314
http://dx.doi.org/10.1177/24741264231163393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621699/
https://www.ncbi.nlm.nih.gov/pubmed/37927314
http://dx.doi.org/10.1177/24741264231163393

Ejemplares similares